BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36853689)

  • 1. Efficient bi-allelic tagging in human induced pluripotent stem cells using CRISPR.
    Ren X; Takagi MA; Shen Y
    STAR Protoc; 2023 Mar; 4(1):102084. PubMed ID: 36853689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Efficient Knock-in Mouse and Human Pluripotent Stem Cells Using CRISPR-Cas9.
    Anzai T; Hara H; Chanthra N; Sadahiro T; Ieda M; Hanazono Y; Uosaki H
    Methods Mol Biol; 2021; 2320():247-259. PubMed ID: 34302663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASSURED-optimized CRISPR protocol for knockout/SNP knockin in hiPSCs.
    Ludwik KA; Telugu N; Schommer S; Stachelscheid H; Diecke S
    STAR Protoc; 2023 Sep; 4(3):102406. PubMed ID: 37481731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome Editing in Human Induced Pluripotent Stem Cells (hiPSCs).
    Higo S; Hikoso S; Miyagawa S; Sakata Y
    Methods Mol Biol; 2021; 2320():235-245. PubMed ID: 34302662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9-Mediated Fluorescent Tagging of Endogenous Proteins in Human Pluripotent Stem Cells.
    Sharma A; Toepfer CN; Ward T; Wasson L; Agarwal R; Conner DA; Hu JH; Seidman CE
    Curr Protoc Hum Genet; 2018 Jan; 96():21.11.1-21.11.20. PubMed ID: 29364519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation.
    Xu X; Gao D; Wang P; Chen J; Ruan J; Xu J; Xia X
    Sci Rep; 2018 Aug; 8(1):11649. PubMed ID: 30076383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
    Yumlu S; Bashir S; Stumm J; Kühn R
    Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
    Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
    Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of Hemoglobin E/Beta-Thalassemia Patient-Derived iPSCs Using CRISPR/Cas9.
    Wattanapanitch M
    Methods Mol Biol; 2021; 2211():193-211. PubMed ID: 33336279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Derivation of Multi-Reporter Pluripotent Stem Cell Lines via CRISPR/Cas9n-Mediated Homology-Directed Repair.
    Dettmer R; Naujok O
    Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e116. PubMed ID: 32628328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protocol of tagging endogenous proteins with fluorescent tags using CRISPR-Cas9 genome editing.
    Wu ZS; Gao Y; Du YT; Dang S; He KM
    Yi Chuan; 2023 Feb; 45(2):165-175. PubMed ID: 36927663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
    Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
    Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of CRISPR/Cas ribonucleoproteins for high throughput gene editing of induced pluripotent stem cells.
    Wang Q; Chear S; Wing K; Stellon D; Nguyen Tran MT; Talbot J; Pébay A; Hewitt AW; Cook AL
    Methods; 2021 Oct; 194():18-29. PubMed ID: 33607266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation.
    Dannenmann B; Nasri M; Welte K; Skokowa J
    Methods Mol Biol; 2020; 2115():471-483. PubMed ID: 32006418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-Mediated Gene Knockout and Knockin Human iPSCs.
    Petazzi P; Menéndez P; Sevilla A
    Methods Mol Biol; 2022; 2454():559-574. PubMed ID: 33190185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Disruption Using CRISPR-Cas9 Technology.
    Hu N; Malek SN
    Methods Mol Biol; 2019; 1881():201-209. PubMed ID: 30350208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-mediated one step bi-allelic change of genomic DNA in iPSCs and human RPE cells in vitro with dual antibiotic selection.
    Supharattanasitthi W; Carlsson E; Sharif U; Paraoan L
    Sci Rep; 2019 Jan; 9(1):174. PubMed ID: 30655567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing Gene Editing Efficiency for CRISPR-Cas9 by Small RNAs in Pluripotent Stem Cells.
    Shahryari A; Moya N; Siehler J; Wang X; Burtscher I; Lickert H
    CRISPR J; 2021 Aug; 4(4):491-501. PubMed ID: 34406042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR Base Editing in Induced Pluripotent Stem Cells.
    Chang YJ; Xu CL; Cui X; Bassuk AG; Mahajan VB; Tsai YT; Tsang SH
    Methods Mol Biol; 2019; 2045():337-346. PubMed ID: 31250381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Cold shock' increases the frequency of homology directed repair gene editing in induced pluripotent stem cells.
    Guo Q; Mintier G; Ma-Edmonds M; Storton D; Wang X; Xiao X; Kienzle B; Zhao D; Feder JN
    Sci Rep; 2018 Feb; 8(1):2080. PubMed ID: 29391533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.